TY  - JOUR
AU  - Reig, Anna
AU  - Álvarez-Navascués, Carmen
AU  - Vergara, Mercedes
AU  - Gómez-Domínguez, Elena
AU  - Gallego-Moya, Adolfo
AU  - Pérez-Medrano, Indhira M
AU  - Fábrega, Emilio
AU  - Hernández-Guerra, Manuel
AU  - Berenguer, Marina
AU  - Estevez, Pamela
AU  - Arencibia, Ana
AU  - Morillas, Rosa M
AU  - Horta, Diana
AU  - Albillos, Agustín
AU  - Casado, Marta
AU  - De la Cruz, Gema
AU  - Fernandez-Bonilla, Eva
AU  - Molina, Esther
AU  - Hijona, Lander
AU  - Diago, Moises
AU  - Fernández-Rodriguez, Conrado M
AU  - González-Santiago, Jesús M
AU  - Sala, Margarita
AU  - Gómez-Camarero, Judith
AU  - Romero-Gomez, Manuel
AU  - Suárez, Francisco
AU  - Vargas, Victor
AU  - Ferre-Aracil, Carlos
AU  - Andrade, Raúl J
AU  - Chahri, Nadia
AU  - Parés, Albert
PY  - 2021
DO  - 10.14309/ajg.0000000000001343
UR  - https://hdl.handle.net/10668/24992
T2  - The American journal of gastroenterology
AB  - Obeticholic acid (OCA) and fibrates therapy results in biochemical improvement in placebo-controlled trials in patients with primary biliary cholangitis and insufficient response to ursodeoxycholic acid. There is scarce information outside of clinical...
LA  - en
KW  - Bezafibrate
KW  - Chenodeoxycholic Acid
KW  - Female
KW  - Fenofibrate
KW  - Humans
KW  - Liver Cirrhosis, Biliary
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Treatment Outcome
TI  - Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
TY  - research article
VL  - 116
ER  -